More on FDA’s EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate
Here’s what Eagle’s Chief Technical Officer and the current Chairman of the USP Microbiology Expert Committee, Dr. David Hussong says about the Emergency Use Authorization (EUA) of hydroxychloroquine sulfate and chloroquine phosphate issued by the FDA on March 29, 2020.
More details on the EUA are available in this article.
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Antimicrobial Effectiveness | USP 795 & 797 Revisions - July 18, 2023
- 2023 PDA/FDA Joint Regulatory Conference, 09/18 – 09/20 - July 11, 2023
- APC: Compounders on Capitol Hill, 09/19 – 09/20 - July 11, 2023
